AAMI/FDA Announce Infusion Pump Summit

AAMI and FDA have announced a groundbreaking summit aimed at improving the safety of infusion pumps. The summit is scheduled take place Oct. 5-6 at FDA headquarters in Silver Spring, MD.Now is the time to have your voice heard in this unprecedented effort to build a consensus and find constructive solutions to one of the top concerns in the healthcare community.

August 3, 2010

1 Min Read
AAMI/FDA Announce Infusion Pump Summit

Infusion pumps are among the most widely used medical devices in today's healthcare system. Yet, between 2005 and 2009, FDA has received approximately 56,000 adverse events associated with their use.

This summit will be open to individuals and organizations that have a key interest in the improvement of these devices and in patient safety. Expected participants include:

  • Hospital and industry senior executives

  • Design engineers

  • Researchers and developers of drug delivery devices

  • Academicians

  • Pharmacists

  • Nurses

  • Surgical technologists

  • Human factors engineers

  • Clinical engineers

  • Biomedical equipment technologists

  • Quality system and standards compliance managers

  • Risk managers

The summit will bring together key stakeholders to develop concrete action plans that will improve the design, engineering, manufacturing, and use of infusion pumps—including data collection, user interface, safety standards, insulin infusion, and human factors.

In support of the summit, the following organizations will work with AAMI and FDA to build awareness among their constituents and memberships about the event:

Association of periOperative Registered Nurses (AORN)
Center for Integration of Medicine and Innovative Technology (CIMIT)
Parenteral Drug Association (PDA)
Association of Surgical Technologists (AST)

Registration is required.

For more information about the summit, including the agenda and hotel information, click here.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like